Department of Radiology, University of Würzburg, Würzburg, Germany.
Department of Radiology, University of Pennsylvania, Philadelphia, PA, USA.
Eur Radiol. 2023 Nov;33(11):7913-7922. doi: 10.1007/s00330-023-09770-2. Epub 2023 May 31.
We conducted a systematic review and individual participant data meta-analysis of publications reporting the ophthalmologic presentation, clinical exam, and orbital MRI findings in patients with giant cell arteritis and ocular manifestations.
PubMed and Cochrane databases were searched up to January 16, 2022. Publications reporting patient-level data on patients with ophthalmologic symptoms, imaged with orbital MRI, and diagnosed with biopsy-proven giant cell arteritis were included. Demographics, clinical symptoms, exam, lab, imaging, and outcomes data were extracted. The methodological quality and completeness of reporting of case reports were assessed.
Thirty-two studies were included comprising 51 patients (females = 24; median age, 76 years). Vision loss (78%) and headache (45%) were commonly reported visual and cranial symptoms. Ophthalmologic presentation was unilateral (41%) or bilateral (59%). Fundus examination most commonly showed disc edema (64%) and pallor (49%). Average visual acuity was very poor (2.28 logMAR ± 2.18). Diagnoses included anterior (61%) and posterior (16%) ischemic optic neuropathy, central retinal artery occlusion (8%), and orbital infarction syndrome (2%). On MRI, enhancement of the optic nerve sheath (53%), intraconal fat (25%), and optic nerve/chiasm (14%) was most prevalent. Among patients with monocular visual symptoms, 38% showed pathologic enhancement in the asymptomatic orbit. Six of seven cases reported imaging resolution after treatment on follow-up MRIs.
Vision loss, pallid disc edema, and optic nerve sheath enhancement are the most common clinical, fundoscopic, and imaging findings reported in patients diagnosed with giant cell arteritis with ocular manifestations, respectively. MRI may detect subclinical inflammation and ischemia in the asymptomatic eye and may be an adjunct diagnostic tool.
Brain and orbital MRIs may have diagnostic and prognostic roles in patients with suspected giant cell arteritis who present with ophthalmic symptoms.
我们对报告巨细胞动脉炎(giant cell arteritis,GCA)伴眼部表现患者的眼科表现、临床检查和眼眶 MRI 结果的出版物进行了系统评价和个体参与者数据荟萃分析。
检索了 PubMed 和 Cochrane 数据库,截至 2022 年 1 月 16 日。纳入报告了眼科症状、眼眶 MRI 成像和经活检证实为巨细胞动脉炎的患者的患者水平数据的出版物。提取人口统计学、临床症状、检查、实验室、影像学和结局数据。评估病例报告的方法学质量和报告的完整性。
共纳入 32 项研究,包括 51 例患者(女性 24 例;中位年龄 76 岁)。视力丧失(78%)和头痛(45%)是常见的视觉和颅神经症状。眼科表现为单侧(41%)或双侧(59%)。眼底检查最常见的表现为视盘水肿(64%)和苍白(49%)。平均视力非常差(2.28 logMAR±2.18)。诊断包括前部(61%)和后部(16%)缺血性视神经病变、视网膜中央动脉阻塞(8%)和眼眶梗死综合征(2%)。MRI 显示视神经鞘增强(53%)、眶内脂肪增强(25%)和视神经/视交叉增强(14%)最为常见。在有单眼视觉症状的患者中,38%的无症状眼出现病理性增强。在 7 例随访 MRI 中,有 6 例报告影像学改善。
在诊断为巨细胞动脉炎伴眼部表现的患者中,视力丧失、苍白的视盘水肿和视神经鞘增强分别是最常见的临床、眼底镜和影像学表现。MRI 可能在可疑巨细胞动脉炎患者出现眼部症状时检测到无症状眼的亚临床炎症和缺血,并且可能是一种辅助诊断工具。
对于出现眼部症状的疑似巨细胞动脉炎患者,脑部和眼眶 MRI 可能具有诊断和预后作用。